Table 2

Study patient characteristics

CharacteristicsLow activityModerate activityHigh activityTotal
(N=13 366)(N=22 526)(N=29 469)(N=65 361)
Age band—no (%)
 18–343822 (28.6)7149 (31.7)8823 (29.9)19 794 (30.3)
 35–495975 (44.7)9273 (41.2)13 341 (45.3)28 589 (43.7)
 50–592517 (18.8)4013 (17.8)5114 (17.4)11 644 (17.8)
 60+1052 (7.9)2091 (9.3)2191 (7.4)5334 (8.2)
Sex—no (%)
 Female7658 (57.3)11 276 (50.1)12 564 (42.6)31 498 (48.2)
 Male5708 (42.7)11 250 (49.9)16 905 (57.4)33 863 (51.8)
RUB—no (%)
 0—Non-users835 (6.2)1549 (6.9)2322 (7.9)4706 (7.2)
 1—Healthy users1169 (8.7)2134 (9.5)3215 (10.9)6518 (10)
 2—Low morbidity2161 (16.2)3811 (16.9)5104 (17.3)11 076 (16.9)
 3—Moderate7176 (53.7)12 010 (53.3)15 651 (53.1)34 837 (53.3)
 4—High1492 (11.2)2280 (10.1)2534 (8.6)6306 (9.6)
 5—Very high533 (4)742 (3.3)643 (2.2)1918 (2.9)
Chronic conditions—no (%)
 Oncology308 (2.30)533 (2.37)616 (2.09)1457 (2.23)
 Essential hypertension2115 (15.82)3254 (14.45)3284 (11.14)8653 (13.24)
 Hypercholesterolaemia1440 (10.77)2322 (10.31)2426 (8.23)6188 (9.47)
 Asthma809 (6.05)1299 (5.77)1827 (6.2)3935 (6.02)
 Diabetes mellitus918 (6.87)1183 (5.25)931 (3.16)3032 (4.64)
 Hypothyroidism432 (3.23)636 (2.82)746 (2.53)1814 (2.78)
 HIV infection274 (2.05)427 (1.90)297 (1.01)998 (1.53)
 Epilepsy165 (1.23)235 (1.04)291 (0.99)691 (1.06)
 Rheumatoid arthritis151 (1.13)211 (0.94)211 (0.72)573 (0.88)
 Conduction disorder104 (0.78)199 (0.88)207 (0.70)510 (0.78)
 Congestive cardiac failure78 (0.58)100 (0.44)68 (0.23)246 (0.38)
 Ulcerative colitis50 (0.37)81 (0.36)91 (0.31)222 (0.34)
 Systemic lupus erythematosus57 (0.43)55 (0.24)53 (0.18)165 (0.25)
 Chronic renal failure43 (0.32)57 (0.25)50 (0.17)150 (0.23)
 Crohn’s disease25 (0.19)40 (0.18)55 (0.19)120 (0.18)
 Cardiomyopathy25 (0.19)41 (0.18)39 (0.13)105 (0.16)
 Multiple sclerosis15 (0.11)31 (0.14)34 (0.12)80 (0.12)
 Bronchiectasis4 (0.03)10 (0.04)16 (0.05)30 (0.05)
 Angina syndrome4 (0.03)5 (0.02)13 (0.04)22 (0.03)
  • RUB, resource utilisation bands.